🇺🇸 FDA
Pipeline program

Stereotactic Radiation Therapy

GTM-104

Approved other terminated

Quick answer

Stereotactic Radiation Therapy for Glioblastoma is a Approved program (other) at GT Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
GT Biopharma
Indication
Glioblastoma
Phase
Approved
Modality
other
Status
terminated

Clinical trials